Biggest changeFiscal Year 2022 Fiscal Year 2021 Fiscal Year 2020 Percentage of net revenue: Total costs applicable to revenue 46.2 % 43.5 % 46.0 % Selling, general and administrative expenses 45.6 % 43.3 % 42.4 % Total operating expenses 50.8 % 48.1 % 49.0 % Income from operations 3.1 % 8.4 % 5.1 % Net income 2.1 % 6.2 % 2.1 % Adjusted Operating Income 4.4 % 9.8 % 7.8 % Adjusted EBITDA 9.0 % 14.2 % 12.8 % 54 Table of Contents Fiscal Year 2022 compared to Fiscal Year 2021 Net revenue The following presents, by segment and by brand, comparable store sales growth, stores open at the end of the period and net revenue for fiscal year 2022 compared to fiscal year 2021.
Biggest changeFiscal Year 2023 Fiscal Year 2022 Fiscal Year 2021 Percentage of net revenue: Total costs applicable to revenue 47.1 % 46.2 % 43.5 % Selling, general and administrative expenses 46.6 % 45.6 % 43.3 % Total operating expenses 55.1 % 50.8 % 48.1 % Income (loss) from operations (2.2) % 3.1 % 8.4 % Net income (loss) (3.1) % 2.1 % 6.2 % Adjusted Operating Income 3.4 % 4.4 % 9.8 % Adjusted EBITDA 7.8 % 9.0 % 14.2 % Fiscal Year 2023 compared to Fiscal Year 2022 Net revenue The following presents, by segment and by brand, comparable store sales growth, stores open at the end of the period and net revenue for fiscal year 2023 compared to fiscal year 2022. 53 Table of Contents Comparable store sales growth (1) Stores open at end of period Net revenue (2) In thousands, except percentage and store data Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2022 Owned & Host segment America’s Best 4.0 % (7.7) % 957 905 $ 1,470,411 69.1 % $ 1,366,019 68.1 % Eyeglass World (1.0) % (6.7) % 148 136 225,906 10.6 % 217,727 10.9 % Military 3.0 % (4.3) % 54 54 22,758 1.1 % 22,114 1.1 % Fred Meyer (4.6) % (5.1) % 29 29 10,973 0.5 % 11,508 0.6 % Owned & Host segment total 1,188 1,124 $ 1,730,048 81.3 % $ 1,617,368 80.6 % Legacy segment (0.5) % (8.4) % 225 230 150,894 7.1 % 151,877 7.6 % Corporate/Other — — — — 252,427 11.9 % 242,822 12.1 % Reconciliations — — — — (6,901) (0.3) % (6,663) (0.3) % Total 3.1 % (7.5) % 1,413 1,354 $ 2,126,468 100.0 % $ 2,005,404 100.0 % Adjusted Comparable Store Sales Growth (3) 2.9 % (7.6) % _________ (1) We calculate total comparable store sales based on consolidated net revenue excluding the impact of (i) Corporate/Other segment net revenue, (ii) sales from stores opened less than 13 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month and (v) if applicable, the impact of a 53rd week in a fiscal year.
Item 8. of this Form 10-K, with the exception of the Legacy segment, which is adjusted as noted in clause (ii) of footnote (3) below. (2) Percentages reflect line item as a percentage of net revenue, adjusted for rounding.
Item 8. of this Form 10-K, with the exception of the Legacy segment, which is adjusted as noted in clause (ii) of footnote (3) below. (2) Percentages reflect line item as a percentage of net revenue, adjusted for rounding.
Legacy segment managed care net product revenue is recorded in net product sales while revenue associated with servicing non-managed care customers is recorded in net sales of services and plans. Eyeglass and contact lens product costs for both managed care and non-managed care net revenue are recorded in costs of products.
Legacy segment managed care net product revenue is recorded in net product sales while revenue associated with servicing non-managed care customers is recorded in net sales of services and plans. Eyeglass and contact lens product costs for both managed care and non-managed care net revenue are recorded in costs of products.
Increases in managed care mix decrease costs of products as a percentage of net product sales and have a corresponding negative impact on costs of services as a percentage of net sales of services and plans in our Legacy segment.
Increases in managed care mix decrease costs of products as a percentage of net product sales and have a corresponding negative impact on costs of services as a percentage of net sales of services and plans in our Legacy segment.
Net Cash Used for Investing Activities Net cash used for investing activities increased by $18.0 million, to $110.9 million, during fiscal year 2022 from $92.9 million during fiscal year 2021. The increase was primarily due to increased capital investments in remote medicine and new store openings. We purchased $113.5 million in capital items during fiscal year 2022.
Net cash used for investing activities increased by $18.0 million, to $110.9 million, during fiscal year 2022 from $92.9 million during fiscal year 2021. The increase was primarily due to increased capital investments in remote medicine and new store openings. We purchased $113.5 million in capital items during fiscal year 2022.
Some of these limitations are: • they do not reflect costs or cash outlays for capital expenditures or contractual commitments; • they do not reflect changes in, or cash requirements for, our working capital needs; • EBITDA, Adjusted EBITDA and Adjusted Operating Income do not reflect the interest expense (income), net or the cash requirements necessary to service interest or principal payments, on our debt; • EBITDA, Adjusted EBITDA and Adjusted Operating Income do not reflect period to period changes in taxes, income tax provision or the cash necessary to pay income taxes; 61 Table of Contents • they do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect cash requirements for such replacements; and • other companies in our industry may calculate these measures differently than we do, limiting their usefulness as comparative measures.
Some of these limitations are: • they do not reflect costs or cash outlays for capital expenditures or contractual commitments; • they do not reflect changes in, or cash requirements for, our working capital needs; • EBITDA, Adjusted EBITDA and Adjusted Operating Income do not reflect the interest expense (income), net or the cash requirements necessary to service interest or principal payments, on our debt; • EBITDA, Adjusted EBITDA and Adjusted Operating Income do not reflect period to period changes in taxes, income tax provision or the cash necessary to pay income taxes; 60 Table of Contents • they do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect cash requirements for such replacements; and • other companies in our industry may calculate these measures differently than we do, limiting their usefulness as comparative measures.
Depending on our liquidity levels, conditions in the capital markets and other factors, we may from time to time consider the refinancing or issuance of debt, issuance of equity or other securities, the proceeds of which could provide additional liquidity for our operations, as well as modifications to our term loan where possible.
Depending on our liquidity levels, conditions in the capital markets and other factors, we may from time to time consider the prepayment, refinancing or issuance of debt, issuance of equity or other securities, the proceeds of which could provide additional liquidity for our operations, as well as modifications to our term loan where possible.
Many factors affect comparable store sales, including: • consumer confidence, preferences and buying trends and overall economic trends including inflation and the amount and timing of tax refunds; • the availability of optometrists and other vision care professionals; • advertising strategies; • participation in managed care programs; • the recurring nature of eye care purchases; • our ability to identify and respond effectively to customer preferences and trends; • our ability to provide an assortment of high quality/low-cost product offerings that generate new and repeat visits to our stores; • foot traffic in retail shopping centers where our stores are predominantly located; • the customer experience we provide in our stores; • our ability to source and receive products accurately and timely; • changes in product pricing, including promotional activities; • the number of items purchased per store visit; • the number of stores that have been in operation for more than 12 months; • impact of competition and consolidation in the U.S. optical retail industry; • impact and timing of weather related store closures; and • public health emergencies, like COVID-19, which may exacerbate the effects and relevant risk exposures listed above.
Many factors affect comparable store sales, including: • consumer confidence, preferences and buying trends and overall economic trends including inflation and the amount and timing of tax refunds; 49 Table of Contents • the availability of optometrists and other vision care professionals; • advertising strategies; • participation in managed care programs; • the recurring nature of eye care purchases; • our ability to identify and respond effectively to customer preferences and trends; • our ability to provide an assortment of high quality/low-cost product offerings that generate new and repeat visits to our stores; • foot traffic in retail shopping centers where our stores are predominantly located; • the customer experience we provide in our stores; • our ability to source and receive products accurately and timely; • changes in product pricing, including promotional activities; • the number of items purchased per store visit; • the number of stores that have been in operation for more than 12 months; • impact of competition and consolidation in the U.S. optical retail industry; • impact and timing of weather-related store closures; and • public health emergencies, like COVID-19, which may exacerbate the effects and relevant risk exposures listed above.
For further information, please see “Risk Factors” and “Forward-Looking Statements.” Overview We are one of the largest optical retailers in the United States and a leader in the attractive value segment of the U.S. optical retail industry.
For further information, please see “Risk Factors” and “Forward-Looking Statements.” Overview We are one of the largest optical retailers in the United States (the “U.S.”) and a leader in the attractive value segment of the U.S. optical retail industry.
Net product sales decreased $70.0 million, or 4.1% during fiscal year 2022 compared to fiscal year 2021, primarily due to a $80.7 million, or 6.7%, decrease in eyeglass sales, which was partially offset by a $6.4 million, or 1.7%, increase in contact lens sales and a $4.3 million, or 3.2%, increase in wholesale fulfillment. 55 Table of Contents Net sales of services and plans decreased $4.1 million, or 1.1%, driven primarily by a $7.1 million, or 16.9%, decrease in management fees from our Legacy partner, which was partially offset by a $5.6 million, or 2.9%, increase in exam revenues.
Net product sales decreased $70.0 million, or 4.1% during fiscal year 2022 compared to fiscal year 2021, primarily due to a $80.7 million, or 6.7%, decrease in eyeglass sales, which was partially offset by a $6.4 million, or 1.7%, increase in contact lens sales and a $4.3 million, or 3.2%, increase in wholesale fulfillment. 57 Table of Contents Net sales of services and plans decreased $4.1 million, or 1.1%, driven primarily by a $7.1 million, or 16.9%, decrease in management fees from our Legacy partner, which was partially offset by a $5.6 million, or 2.9%, increase in exam revenues.
See Note 7. “Revenue from Contracts With Customers” in our audited consolidated financial statements included in Part II. Item 8. of this Form 10-K for additional information.
See Note 8. “Revenue from Contracts with Customers” in our audited consolidated financial statements included in Part II. Item 8. of this Form 10-K for additional information.
Significant unobservable inputs used in the fair value measurement of the reporting units include revenue growth rates, payroll and other expense growth rates, capital expenditures and discount rates. These assumptions are sensitive to future changes in the business profitability, changes in our business strategy, customer concentration risk and external market conditions, among other factors. See Note 3.
Significant unobservable inputs used in the fair value measurement of the reporting units include revenue growth rates, payroll and other expense growth rates, capital expenditures and discount rates. These assumptions are sensitive to future changes in the business profitability, changes in our business strategy, customer concentration risk and external market conditions, among other factors. See Note 4.
We believe the impacts of the COVID-19 pandemic on vision care professional availability, including a competitive recruiting market and preferences for adjusted work schedules, and the demand for optometrists exceeding supply in certain areas during fiscal year 2022 have caused constraints in exam capacity which are continuing.
We believe the impacts of the COVID-19 pandemic on vision care professional availability, including a competitive recruiting market and preferences for adjusted work schedules, and the demand for optometrists exceeding supply in certain areas during fiscal year 2023 have caused constraints in exam capacity which are continuing.
We define Adjusted EBITDA as net income, plus interest expense (income), net, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock based compensation expense, loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, and certain other expenses.
We define Adjusted EBITDA as net income, plus interest expense (income), net, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock-based compensation expense, loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, ERP implementation expenses and certain other expenses.
A 100 basis point change in our estimate of value delivered to customers compared to expected customer usage of benefits would have affected revenues in fiscal year 2022 by approximately $2 million; this amount would have been recognized at different times over the contract period.
A 100 basis point change in our estimate of value delivered to customers compared to expected customer usage of benefits would have affected revenues in fiscal year 2023 by approximately $2 million; this amount would have been recognized at different times over the contract period.
We allocate each lease payment between a reduction of the lease obligation and interest expense using the effective interest method. Finance lease amounts above represent required contractual cash payments in the periods presented. Refer to Note 8. “Leases” for our current and long-term lease payment obligations.
We allocate each lease payment between a reduction of the lease obligation and interest expense using the effective interest method. Finance lease amounts above represent required contractual cash payments in the periods presented. Refer to Note 9. “Leases” for our current and long-term lease payment obligations.
With respect to our fourth quarter results, compared to other retailers, our products and services are less likely to be included in consumer’s holiday spending budgets, therefore reducing spending on personal vision correction during the weeks preceding December 25th of each year.
With respect to our fourth quarter results, compared to other retailers, our products and services are less likely to be included in consumers’ holiday spending budgets, therefore reducing spending on personal vision correction during the weeks preceding December 25th of each year.
There are no revenue transactions between reportable segments, and there are no other items in the reconciliations other than the effects of unearned and deferred revenue. See Note 14. “Segment Reporting” in our consolidated financial statements included in Part II. Item 8. of this Form 10-K.
There are no revenue transactions between reportable segments, and there are no other items in the reconciliations other than the effects of unearned and deferred revenue. See Note 15. “Segment Reporting” in our consolidated financial statements included in Part II. Item 8. of this Form 10-K.
See “Non-GAAP Financial Measures” for definitions of the Company Non-GAAP Measures and for additional information. 53 Table of Contents Results of Operations The following table summarizes key components of our results of operations for the periods indicated, both in dollars and as a percentage of our net revenue.
See “Non-GAAP Financial Measures” for definitions of the Company Non-GAAP Measures and for additional information. 52 Table of Contents Results of Operations The following table summarizes key components of our results of operations for the periods indicated, both in dollars and as a percentage of our net revenue.
Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 14. “Segment Reporting” in our consolidated financial statements included in Part II.
Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 15. “Segment Reporting” in our consolidated financial statements included in Part II.
SG&A for fiscal year 2022 and fiscal year 2021 includes $0.6 million and $1.5 million, respectively, of incremental costs directly related to adapting the Company’s operations during the COVID-19 pandemic. 56 Table of Contents Owned & Host segment SG&A.
SG&A for fiscal year 2022 and fiscal year 2021 includes $0.6 million and $1.5 million, respectively, of incremental costs directly related to adapting the Company’s operations during the COVID-19 pandemic. 58 Table of Contents Owned & Host segment SG&A.
Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 14. “Segment Reporting” in our consolidated financial statements included in Part II.
Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 15. “Segment Reporting” in our consolidated financial statements included in Part II.
When appropriate, the Company may utilize excess liquidity towards debt service requirements, including voluntary debt prepayments, or required interest and principal payments, if any, as well as repurchases of common stock, based on excess cash flows.
When appropriate, the Company may utilize excess liquidity towards debt service requirements, including voluntary debt prepayments, or required interest and principal payments, if any, as well as repurchases of common stock or other securities, based on excess cash flows.
We operate in the highly competitive and fragmented U.S. optical retail industry. We face competition from mass merchants, specialty retail chains, online retailers and independent eye practitioners and opticians, along with large national retailers.
We operate in the highly competitive and fragmented U.S. optical retail in dustry. We face competition from mass merchants, specialty retail chains, online retailers and independent eye practitioners and opticians, along with large national retailers.
We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Stores Sales Growth to be meaningful. 52 Table of Contents Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Diluted EPS (collectively, the “Company Non-GAAP Measures”) The Company Non-GAAP Measures are key measures used by management to assess our financial performance.
We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Stores Sales Growth to be meaningful. Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Diluted EPS (collectively, the “Company Non-GAAP Measures”) The Company Non-GAAP Measures are key measures used by management to assess our financial performance.
Approximately 80% to 85% of o ur capital spend is related to our expected growth (i.e., new stores, remote medicine infrastructure, EHR, optometric equipment, additional capacity in our optical laboratories and distribution centers, and our IT infrastructure, including omni-channel platform related investments).
Approximately 80% to 85% of our capital spend is related to our expected growth (i.e., new stores, remote medicine infrastructure, EHR, optometric equipment, additional capacity in our optical laboratories and distribution centers, and our IT infrastructure, including ERP and omni-channel platform related investments).
GAAP in making the determination as to whether or not to record an asset or liability related to our arrangements with third parties. Consistent with current accounting guidance, we do not record an asset or liability associated with long-term purchase, marketing and promotional commitments, or commitments to philanthropic endeavors.
We follow U.S. GAAP in making the determination as to whether to record an asset or liability related to our arrangements with third parties. Consistent with current accounting guidance, we do not record an asset or liability associated with long-term purchase, marketing and promotional commitments, or commitments to philanthropic endeavors.
Impairment of P&E and ROU assets In evaluating store-level property and equipment and ROU assets for recoverability and impairment, we may consider multiple factors including financial performance of the stores, regional and local business climates, future plans for the store operations and other qualitative factors.
Impairment of P&E and ROU assets 66 Table of Contents In evaluating store-level property and equipment and ROU assets for recoverability and impairment, we may consider multiple factors including financial performance of the stores, regional and local business climates, future plans for the store operations and other qualitative factors.
(3) There are two differences between total comparable store sales growth based on consolidated net revenue and Adjusted Comparable Store Sales Growth: (i) Adjusted Comparable Store Sales Growth includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in an increase of 0.7% and a decrease of 0.4% from total comparable store sales growth based on consolidated net revenue for fiscal year 2021 and fiscal year 2020, respectively, and (ii) Adjusted Comparable Store Sales Growth includes retail sales to the Legacy partner’s customers (rather than the revenues recognized consistent with the management & services agreement with the Legacy partner), resulting in a decrease of 0.1% and a decrease of 0.1% from total comparable store sales growth based on consolidated net revenue for the fiscal years 2021 and 2020, respectively.
(3) There are two differences between total comparable store sales growth based on consolidated net revenue and Adjusted Comparable Store Sales Growth: (i) Adjusted Comparable Store Sales Growth includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in a decrease of 0.1% and an increase of 0.7% from total comparable store sales growth based on consolidated net revenue for fiscal years 2023 and 2022, respectively, and (ii) Adjusted Comparable Store Sales Growth includes retail sales to the Legacy partner’s customers (rather than the revenues recognized consistent with the management & services agreement with the Legacy partner), resulting in a decrease of 0.1% and a decrease of 0.1% from total comparable store sales growth based on consolidated net revenue for the fiscal years 2023 and 2022, respectively.
“Long-term Debt” to our consolidated financial statements included in Part II. Item 8 of this Form 10-K for more information on our term loan. (b) Refer to Note 4. “Long-term Debt” for more information on the 2025 Notes and Note 13. “Earnings Per Share” for the treatment of earnings per share in relation to the 2025 Notes.
“Long-term Debt” to our consolidated financial statements included in Part II. Item 8 of this Form 10-K for more information on our term loan. (b) Refer to Note 5. “Long-term Debt” for more information on the 2025 Notes and Note 14. “Earnings Per Share” for the treatment of earnings per share in relation to the 2025 Notes.
Consumer behavior driven by the COVID-19 pandemic has resulted in a departure from seasonal norms we have experienced in recent years and may continue to disrupt the historical quarterly cadence of our results of operations for an unknown period of time.
Changes in consumer behavior driven by lingering effects of the COVID-19 pandemic have resulted in a departure from seasonal norms we have experienced in recent years and may continue to disrupt the historical quarterly cadence of our results of operations for an unknown period of time.
While we have relationships with almost all vision care insurers in the United States and with all of the major carriers, currently, a relatively small number of payors comprise the majority of our managed care revenues, subjecting us to concentration risk.
While we have relationships with almost all vision care insurers in the U.S. and with all of the major carriers, currently, a relatively small number of payors comprise the majority of our managed care revenues, subjecting us to concentration risk.
Net Cash Provided by Operating Activities Cash flows provided by operating activities decreased by $139.7 million to $119.2 million, during fiscal year 2022 from $258.9 million during fiscal year 2021 as a result of a $86.1 million decrease in net income, changes in net working capital and other assets and liabilities, which used an additional $38.6 million in cash and a decrease in non-cash expense adjustments of $15.0 million, in each case, as compared to fiscal year 2021.
Cash flows provided by operating activities decreased by $139.7 million to $119.2 million, during fiscal year 2022 from $258.9 million during fiscal year 2021 as a result of a $86.1 million decrease in net income, changes in net working capital and other assets and liabilities, which used an additional $39.9 million in cash and a decrease in non-cash expense adjustments of $13.7 million, in each case, as compared to fiscal year 2021.
The most significant components of our operating assets and liabilities are inventories, accounts receivable, prepaid expenses and other assets, accounts payable, deferred and unearned revenue and other payables and accrued expenses.
The most significant components of our operating assets and liabilities are inventories, accounts receivable, prepaid expenses and other assets, accounts payable, deferred and unearned revenue and other payables and accrued 62 Table of Contents expenses.
Eyeglass World locations primarily feature eye care services provided by independent optometrists and optometrists employed by independent professional corporations or similar entities and on-site optical laboratories that enable stores to quickly fulfill many customer orders and make repairs on site. Eyeglass World stores are primarily located in freestanding or in-line locations near high-foot-traffic shopping centers.
Eyeglass World locations offer eye exams, provided primarily by independent optometrists and optometrists employed by independent professional corporations or similar entities, and have on-site optical laboratories that enable stores to quickly fulfill many customer orders and make repairs on site. Eyeglass World stores are primarily located in freestanding or in-line locations near high-foot-traffic shopping centers.
We adjust for amortization of costs related to the 2025 Notes only when adjustment for these costs is not required in the calculation of diluted earnings per share according to U.S. GAAP.
We adjust for amortization of deferred financing costs related to the 2025 Notes only when adjustment for these costs is not required in the calculation of diluted earnings per share under U.S. GAAP.
Additionally, although the period between December 25th and the end of our fiscal year is typically a high-volume period, the net revenue associated with substantially all orders of prescription eyeglasses and contact lenses during that period is deferred until the following fiscal period due to our policy of recognizing revenue only after the product has been accepted by the customer.
Additionally, although the period between December 25th and the end of our fiscal year is typically a high-volume period, the net revenue associated with substantially all orders of prescription eyeglasses and contact lenses during that period is deferred until the following fiscal period due to our policy of recognizing revenue only after the product has been accepted by the customer, further contributing to higher revenue results in the first half of the year.
We have made significant investments in information technology systems, including our point-of-sale system and enterprise resource planning (ERP), supply chain systems, marketing, and personnel, as well as experienced industry executives, and management and merchandising teams to support our long-term growth objectives.
We have made and continue to make significant investments in information technology systems, including those to support our point-of-sale system, ERP, supply chain systems, marketing, and personnel, as well as experienced industry executives, and management and merchandising teams to support our long-term growth objectives.
As of December 31, 2022, our total inventory balance was $123.2 million. A 10% increase in the obsolescence and shrinkage reserves will not have a material impact on our financial position. See Note 1. “Business and Significant Accounting Policies” to our consolidated financial statements included in Part II. Item 8 of this Form 10-K.
As of December 30, 2023, our total inventory balance was $119.9 million. A 10% increase in the obsolescence and shrinkage reserves will not have a material impact on our financial position. See Note 1. “Business and Significant Accounting Policies” to our consolidated financial statements included in Part II. Item 8 of this Form 10-K.
Amounts and timing may be different from our estimated interest payments due to potential voluntary prepayments, borrowings, interest rate fluctuations and the expected discontinuation of LIBOR. Expected obligations on our hedging instruments are excluded from estimated interest presented in the table above. Refer to Note 1.
Amounts and timing may be different from our estimated interest payments due to potential voluntary prepayments, borrowings and interest rate fluctuations. Expected obligations on our hedging instruments are excluded from estimated interest presented in the table above.
In addition, as our participation in managed care programs continues to approach overall industry penetration levels, we expect our associated managed care revenue growth rate to slow over time. Infrastructure Investment Our historical results of operations reflect the impact of our ongoing investments in infrastructure to support our growth, including additional investments in remote medicine and EHR platforms.
In addition, as our participation in managed care programs continues to approach overall industry penetration levels, we expect our associated managed care revenue growth rate to slow over time. Infrastructure Investment Our historical results of operations reflect the impact of our ongoing investments in infrastructure to support our growth.
Changes in raw materials prices did not materially impact our costs applicable to revenue in fiscal year 2022. We anticipate that pressures from increases to our raw materials prices could have an impact on our costs applicable to revenue in fiscal year 2023. Such an inflationary environment and labor market challenges can also result in wage pressures in certain markets.
We anticipate that pressures from increases to our raw materials prices could have an impact on our costs applicable to revenue in fiscal year 2024. Such an inflationary environment and labor market challenges can also result in wage pressures in certain markets.
Wage investment pressure, increases to costs applicable to revenue from increases in raw materials prices and potential freight price increases in fiscal year 2023 may not be able to be fully offset by leverage from revenue growth, productivity efficiency and, as appropriate, various pricing actions.
Wage investment pressure and increases to costs applicable to revenue from increases in raw materials prices may not be able to be fully offset by leverage from revenue growth, productivity efficiency and, as appropriate, various pricing actions.
As of fiscal year end 2022, we had $229.4 million in cash and cash equivalents and $293.6 million of availability under our revolving credit facility, which includes $6.4 million in outstanding letters of credit.
As of fiscal year end 2023, we had $149.9 million in cash and cash equivalents and $293.6 million of availability under our revolving credit facility, which includes $6.4 million in outstanding letters of credit.
Our net deferred liability balance as of December 31, 2022 was $93.9 million. Changes in assumptions in our estimates could result in material changes to these balances. See Note 6. “Income Taxes” to our consolidated financial statements included in Part II. Item 8 of this Form 10-K.
Our net deferred liability balance as of December 30, 2023 was $87.9 million. Changes in assumptions in our estimates could result in material changes to these balances. See Note 7. “Income Taxes” to our consolidated financial statements included in Part II. Item 8 of this Form 10-K.
Due to these factors the costs to employ or retain optometrists have increased and may increase further, potentially materially. Targeted wage investments, including increases in compensation for our optometrists and associates, and flexibility initiatives have impacted our costs applicable to revenue and selling, general and administrative expenses.
Due to these factors, the costs to employ or retain optometrists have increased and may increase further, potentially materially. Targeted wage investments, including increases in compensation for our optometrists and associates, and flexibility initiatives have impacted our costs applicable to revenue and selling, general and administrative expenses. We anticipate that wage pressures in certain markets will continue in 2024.
We reach our customers through a diverse portfolio of 1,354 retail stores across five brands and 16 consumer websites as of fiscal year end 2022.
We reach our customers through a diverse portfolio of 1,413 retail stores across five brands and 13 consumer websites as of fiscal year end 2023.
We considered multiple factors including, but not limited to: forecasted scenarios related to store performance and the likelihood that these scenarios would be ultimately realized; and the remaining useful lives of the assets.
We considered multiple factors including, but not limited to: forecasted scenarios related to store performance and the likelihood that these scenarios would be ultimately realized; and the remaining useful lives of the assets. Asset impairment expenses were recognized in Corporate/Other.
(c) Refer to Note 4. “Long-term Debt” for more information on our revolving credit facility. (d) We have estimated our interest payments on our term loan based on LIBOR as of the end of fiscal year 2022.
(c) Refer to Note 5. “Long-term Debt” for more information on our revolving credit facility. (d) We have estimated our interest payments on our term loan based on Term Secured Overnight Financing Rate as of the end of fiscal year 2023.
The components of our costs applicable to revenue may not be comparable to other retailers. Selling, General and Administrative SG&A generally fluctuates consistently with revenue due to the variable store, field office and corporate support costs; however, some fixed costs slightly improve as a percentage of net revenue as our net revenues grow over time.
Selling, General and Administrative 51 Table of Contents SG&A generally fluctuates consistently with revenue due to the variable store, field office and corporate support costs; however, some fixed costs slightly improve as a percentage of net revenue as our net revenues grow over time.
(g) Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA), which are primarily related to excess payroll taxes on stock option exercises, executive severance and relocation and other expenses and adjustments, including our share of (gains) losses on equity method investments of $(2.7) million and $(2.4) million for fiscal years 2022 and 2021, respectively, and losses on other investments of $0.3 million for fiscal year 2022.
(i) Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA), which are primarily related to the termination of the Walmart partnership of $7.0 million for fiscal year 2023, costs associated with the digitization of paper-based records of $2.2 million for fiscal year 2023, excess payroll taxes on vesting of restricted stock units and exercises of stock options, executive severance and relocation and other expenses and adjustments, including our share of (gains) losses on equity method investments of $(2.7) million and $(2.4) million for fiscal years 2022 and 2021, respectively, and losses on other investments of $0.3 million for fiscal year 2022.
Long-term Debt The following table sets forth the amounts owed under our term loan and the 2025 Notes and the interest rate on such outstanding amounts, and the amount available for additional borrowing thereunder, as of the end of fiscal year 2022: In thousands Interest Rate (2) Amount Outstanding Amount Available for Additional Borrowing 2025 Notes, due May 15, 2025 Fixed $ 402,497 $ — Term loan, due July 18, 2024 Variable 150,000 — Revolving credit facility, due July 18, 2024 (1) Variable — 293,619 Total $ 552,497 $ 293,619 ____________ (1) At December 31, 2022, the amount available under our revolving credit facility reflected a reduction of $6.4 million of letters of credit outstanding.
Long-term Debt The following table sets forth the amounts owed under our term loan and the 2025 Notes and the interest rate on such outstanding amounts, and the amount available for additional borrowing thereunder, as of the end of fiscal year 2023: In thousands Interest Rate (2) Amount Outstanding Amount Available for Additional Borrowing 2025 Notes, due May 15, 2025 Fixed $ 302,497 $ — Term Loan A, due June 13, 2028 Variable 146,250 — Revolving Loans, due June 13, 2028 (1) Variable — 293,619 Total $ 448,747 $ 293,619 ____________ (1) At December 30, 2023, the amount available under our revolving credit facility reflected a reduction of $6.4 million of letters of credit outstanding.
Developing the estimates and assumptions used in our recovery and impairment evaluations require significant judgment. The cash flows used in estimating fair value were discounted using market rates from 7.5% to 10% in fiscal year 2022. We had $359.8 million of property and equipment, net, and ROU assets of $382.8 million as of December 31, 2022.
Developing the estimates and assumptions used in our recovery and impairment evaluations require significant judgment. The cash flows used in estimating fair value of property and equipment and ROU assets were discounted using market rates from 7.8% to 11.5% in fiscal year 2023.
References herein to “fiscal year 2022” relate to the 52 weeks ended December 31, 2022, references herein to “fiscal year 2021” relate to the 52 weeks ended January 1, 2022 and references herein to “fiscal year 2020” relate to the 53 weeks ended January 2, 2021.
References herein to “fiscal year 2023” relate to the 52 weeks ended December 30, 2023, references herein to “fiscal year 2022” relate to the 52 weeks ended December 31, 2022 and references herein to “fiscal year 2021” relate to the 52 weeks ended January 1, 2022.
During fiscal years 2022 and 2021, the Company repurchased 2.7 million shares of its common stock for $80.0 million, and 1.4 million shares of its common stock for $69.9 million, respectively, under the share repurchase program. After these repurchases, approximately $50 million remains available under the share repurchase authorization as of December 31, 2022.
During fiscal years 2023, 2022, and 2021, the Company repurchased 1.1 million shares of its common stock for $25.0 million, 2.7 million shares of its common stock for $80.0 million, and 1.4 million shares of its common stock for $69.9 million, respectively, under the share repurchase program.
“Goodwill and Intangible Assets” to our consolidated financial statements included in Part II. Item 8. of this Form 10-K for further detail on goodwill impairment. As of December 31, 2022, we had $777.6 million of goodwill, $240.5 million of non-amortizing intangible assets, and $34.7 million of other intangible assets, net of accumulated amortization.
“Goodwill and Intangible Assets” included in Part II. Item 8. of this Form 10-K for further detail on goodwill impairment. As of December 30, 2023, we had $717.5 million of goodwill, $240.5 million of non-amortizing intangible assets, and $20.3 million of other intangible assets, net of accumulated amortization.
Other expense (income), net We recognized a gain of $2.4 million in Other expense (income), net in fiscal year 2021 in connection with the acquisition of our equity method investee by a third party. See Note 1. “Business and Significant Accounting Policies” for further details.
This change was primarily a result of a gain of $2.7 million in Other expense (income), net in fiscal year 2022 that did not occur in fiscal year 2023 in connection with the acquisition of our equity method investee by a third party. See Note 1. “Business and Significant Accounting Policies” for further details.
Our results of operations have been and will continue to be materially affected by the timing and number of new store openings. As stores mature, profitability typically increases significantly.
New Store Openings We expect that new stores will be a key driver of growth in our net revenue and operating profit in the future. Our results of operations have been and will continue to be materially affected by the timing and number of new store openings. As stores mature, profitability typically increases significantly.
The fair values of our other reporting units exceeded their respective carrying values by at least 60%. Future changes in a reporting unit’s business profitability, expected cash flows, changes in business strategy and external market conditions, among other factors, could require us to record an impairment charge for goodwill.
Future changes in a reporting unit’s business profitability, expected cash flows, changes in business strategy and external market conditions, among other factors, could require us to record an impairment charge for goodwill.
Our Host brands consisted of 54 Vista Optical locations on select military bases and 29 Vista Optical locations within select Fred Meyer stores as of fiscal year end 2022. We have strong, long-standing relationships with our Host partners and have maintained each partnership for over 20 years. These brands provide eye exams primarily by independent optometrists.
O ur Host brands consisted of 54 Vista O ptical locations on select military bases a nd 29 Vista O ptical locations within select Fred Meyer stores as of fiscal year end 2023. We have strong, long-standing relationships with our Host partners and have maintained each partners hip for over 20 years.
A one day increase in our estimate of the average days needed to process delivery would have affected revenues in fiscal year 2022 by approximately $ 5 million, which would ultimately have been recorded in the next fiscal year. 67 Table of Contents The Company considers its revenue from managed care customers to include variable consideration and estimates such amounts associated with managed care customer revenues using the history of concessions provided and cash receipts from managed care providers; a 100 basis point change in our rate of concessions granted would have reduced our revenues in fiscal year 2022 by approximately $4 million.
The Company considers its revenue from managed care customers to include variable consideration and estimates such amounts associated with managed care customer revenues using the history of concessions provided and cash receipts from managed care providers; a 100 basis point change in our rate of concessions granted would have reduced our revenues in fiscal year 2023 by approximately $2 million.
Owned & Host segment costs of products. Costs of products as a percentage of net product sales decreased from 28.0% for fiscal year 2020 to 27.4% for fiscal year 2021 driven by increased eyeglass mix and higher eyeglass margin, primarily the effect of the temporary store closures in fiscal year 2020. Legacy segment costs of products.
Owned & Host segment costs of products. Costs of products as a percentage of net product sales decreased from 28.9% for fiscal year 2022 to 28.7% for fiscal year 2023 primarily driven by increased eyeglass mix and higher eyeglass margin. Legacy segment costs of products.
A 100 basis point increase in discount rates used to estimate the fair value of the Company’s reporting units would result in an approximate $3 million impairment of the Company’s goodwill balance in the Legacy segment at the end of fiscal year 2022. The Legacy segment’s operations are sensitive to customer concentration.
A 100 basis point increase in discount rates used to estimate the fair value of the Company’s reporting units would not result in an impairment of goodwill at fiscal year-end.
“Business and Significant Accounting Policies” for more information on the sale. Net Cash Provided by (Used for) Financing Activities Net cash used for financing activities decreased $149.8 million, from $234.3 million use of cash during fiscal year 2021 to $84.6 million use of cash during fiscal year 2022 .
Net cash used for financing activities decreased $149.8 million, from $234.3 million use of cash during fiscal year 2021 to $84.6 million use of cash during fiscal year 2022.
Deferred revenue represents the timing difference of when we collect the cash from the customer and when services related to product protection plans and eye care club memberships are performed.
Deferred revenue represents the timing difference of when we collect the cash from the customer and when services related to product protection plans and eye care club memberships are performed. Increases or decreases in deferred revenue during the reporting period represent cash collections in excess of, or below the recognition of, previous deferrals.
All brands utilize our centralized laboratories. This segment also includes sales from our America’s Best, Eyeglass World, and Military omni-channel websites. 47 Table of Contents • Legacy – We manage the operations of, and supply inventory and laboratory processing services to, 230 Vision Centers in Walmart retail locations as of fiscal year end 2022.
This segment also includes sales from our America’s Best, Eyeglass World, and Military omni-channel websites. • Legacy – As of fiscal year end 2023, we managed the operations of, and supplied inventory and laboratory processing servi ces to, 225 Vision Centers in Walmart retail locations .
In comparison, the income tax provision associated with fiscal year 2020 reflected our statutory federal and state rate of 25.5% combined with a benefit of $8.0 million associated primarily with the stock option exercises. 60 Table of Contents Non-GAAP Financial Measures Adjusted Operating Income, Adjusted Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS We define Adjusted Operating Income as net income, plus interest expense (income), net and income tax provision (benefit), further adjusted to exclude stock based compensation expense, loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles and certain other expenses.
Our effective tax rate for fiscal year 2021 was 14.1%, reflecting a benefit of $16.5 million primarily from the exercise of stock options and stranded tax effect associated with our matured interest rate swaps during the first quarter of 2021 . 59 Table of Contents Non-GAAP Financial Measures Adjusted Operating Income, Adjusted Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS We define Adjusted Operating Income as net income, plus interest expense (income), net and income tax provision (benefit), further adjusted to exclude stock-based compensation expense, loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, ERP implementation expenses and certain other expenses.
We are continuing to strategically invest in recruitment and retention initiatives, including flexible adjusted work schedules, along with continuing our implementation of remote medicine technologies, which has expanded our offerings while also increasing costs. New Store Openings We expect that new stores will be a key driver of growth in our net revenue and operating profit in the future.
We are continuing to strategically invest in recruitment and retention initiatives, including flexible adjusted work schedules, along with continuing our implementation of remote medicine technologies, which has expanded our offerings while also increasing costs.
AC Lens sales associated with Walmart and Sam’s Club contact lenses distribution arrangements represen ted 7.0% of c onsolidated net revenue during fiscal year 2022 . • Managed care business conducted by FirstSight, our wholly-owned subsidiary that is licensed as a single-service health plan under California law, which arranges for the provision of optometric services at the offices next to certain Walmart stores throughout California, and also issues individual vision plans in connection with our America’s Best operations in California. • Unallocated corporate overhead expenses, which are a component of selling, general and administrative expenses and are comprised of various home office expenses such as payroll, occupancy costs and consulting and professional fees.
In connection with the MSA Termination, AC Lens has delivered notices of non-renewal of the agreements it has with Walmart and Sam’s Club such that those agreements are expected to terminate on June 30, 2024. • Managed care business conducted by FirstSight, our wholly-owned subsidiary that is licensed as a single-service health plan under California law, which issues individual vision plans in connection with our America’s Best operations in California and, until the termination of the agreement between FirstSight and Walmart on February 23, 2024, arranged for the provision of optometric services at the offices next to certain Walmart stores throughout California. • Unallocated corporate overhead expenses, which are a component of selling, general and administrative expenses and are comprised of various home office expenses such as payroll, occupancy costs and consulting and professional fees.
If the projected net undiscounted cash flows are less than the carrying value of the related assets, we then measure impairment based on a discounted cash flow model and record an impairment charge as the excess of carrying value over the estimated fair value.
If the projected net undiscounted cash flows are less than the carrying value of the related assets, we then measure impairment based on a discounted cash flow model and record an impairment charge as the excess of carrying value over the estimated fair value. 67 Table of Contents Income Taxes Calculations and assessments of uncertain tax positions involve estimates and complex judgments because the ultimate tax outcomes are uncertain and future events are unpredictable.
Some of the percentage totals in the table above do not foot due to rounding differences. 62 Table of Contents In thousands, except per share amounts Fiscal Year 2022 Fiscal Year 2021 Fiscal Year 2020 Diluted EPS $ 0.52 $ 1.43 $ 0.44 Stock based compensation expense (a) 0.17 0.15 0.13 Asset impairment (b) 0.07 0.05 0.27 Litigation settlement (c) — 0.02 0.05 Amortization of acquisition intangibles (d) 0.09 0.08 0.09 Amortization of debt discounts and deferred financing costs (e) 0.04 0.02 0.14 Losses (gains) on change in fair value of derivatives (f) (0.20) (0.03) 0.05 Other (j) (0.00) (0.01) 0.03 Tax benefit of stock option exercises (h) (0.00) (0.15) (0.10) Tax effect of total adjustments (i) (0.04) (0.08) (0.19) Adjusted Diluted EPS $ 0.65 $ 1.48 $ 0.91 Weighted average diluted shares outstanding 80,298 96,134 82,793 Note: Fiscal years 2022 and 2021 include 52 weeks.
Some of the percentage totals in the table above do not foot due to rounding differences. 61 Table of Contents In thousands, except per share amounts Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2021 Diluted EPS $ (0.84) $ 0.52 $ 1.43 Stock-based compensation expense (a) 0.26 0.17 0.15 Loss on extinguishment of debt (b) 0.01 — — Asset impairment (c) 1.05 0.07 0.05 Litigation settlement (d) — — 0.02 Amortization of acquisition intangibles (e) 0.07 0.09 0.08 Amortization of debt discounts and deferred financing costs (f) 0.04 0.04 0.02 Derivative fair value adjustments (g) 0.12 (0.20) (0.03) ERP implementation expenses (h) 0.01 — — Other (l) 0.14 (0.00) (0.01) Tax expense (benefit) from stock-based compensation (j) 0.02 (0.00) (0.15) Tax effect of total adjustments (k) (0.23) (0.04) (0.08) Adjusted Diluted EPS $ 0.64 $ 0.65 $ 1.48 Weighted average diluted shares outstanding 78,313 80,298 96,134 Note: Some of the totals in the table above do not foot due to rounding differences. ____________ (a) Non-cash charges related to stock-based compensation programs, which vary from period to period depending on the timing of awards and performance vesting conditions.
GAAP to be added back for diluted earnings per share, losses (gains) on change in fair value of derivatives, certain other expenses, and tax benefit of stock option exercises, less the tax effect of these adjustments.
GAAP to be added back for diluted earnings per share, derivative fair value adjustments, ERP implementation expenses, certain other expenses, and tax expense (benefit) from stock-based compensation, less the tax effect of these adjustments.
Brand and Segment Information Our operations consist of two reportable segments: • Owned & Host – As of fiscal ye ar end 2022, our owned brands consisted of 905 America’s Best Contacts and Eyeglasses (“America’s Best”) retail stores and 136 Eyeglass World retail stores.
Brand and Segment Information As of December 30, 2023, our operations consisted of two reportable segments: • Owned & Host – As of fiscal ye ar end 2023, our owned brands consist ed of 957 Am erica’s Best Contacts and Eyeglasses (“America’s Best”) retail stores an d 148 Eyeglas s World retail stores.
For fiscal years 2022 and 2021, approximately 23% of our revenue was recorded in the fourth quarter, but approximately 26% and 25% of annual SG&A costs were recorded in the respective fourth quarters of these fiscal years. 51 Table of Contents How We Assess the Performance of Our Business We consider a variety of financial and operating measures in assessing the performance of our business.
For fiscal years 2023 and 2022, approximately 24% and 23% of our revenue was recorded in the fourth quarter, but approximately 25% and 26% of annual SG&A costs were recorded in the respective fourth quarters of these fiscal years.
In thousands, except earnings per share, percentage and store data Fiscal Year 2022 Fiscal Year 2021 Fiscal Year 2020 Revenue: Net product sales $ 1,648,315 $ 1,718,344 $ 1,418,283 Net sales of services and plans 357,089 361,181 293,477 Total net revenue 2,005,404 2,079,525 1,711,760 Costs applicable to revenue (exclusive of depreciation and amortization): Products 636,324 633,116 551,783 Services and plans 289,263 271,663 234,841 Total costs applicable to revenue 925,587 904,779 786,624 Operating expenses: Selling, general and administrative expenses 915,355 900,798 724,985 Depreciation and amortization 99,956 97,089 91,585 Asset impairment 5,783 4,427 22,004 Other income, net (2,552) (2,505) (445) Total operating expenses 1,018,542 999,809 838,129 Income from operations 61,275 174,937 87,007 Interest expense, net 462 25,612 48,327 Earnings before income taxes 60,813 149,325 38,680 Income tax provision 18,691 21,081 2,403 Net income $ 42,122 $ 128,244 $ 36,277 Supplemental operating data: Number of stores open at end of period 1,354 1,278 1,205 New stores opened during the period 80 75 62 Adjusted Operating Income (1) $ 87,795 $ 204,749 $ 134,148 Diluted EPS $ 0.52 $ 1.43 $ 0.44 Adjusted Diluted EPS (1) $ 0.65 $ 1.48 $ 0.91 Adjusted EBITDA (1) $ 180,263 $ 294,350 $ 218,307 Note: Fiscal years 2022 and 2021 include 52 weeks.
In thousands, except earnings per share, percentage and store data Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2021 Revenue: Net product sales $ 1,744,136 $ 1,648,315 $ 1,718,344 Net sales of services and plans 382,332 357,089 361,181 Total net revenue 2,126,468 2,005,404 2,079,525 Costs applicable to revenue (exclusive of depreciation and amortization): Products 664,589 636,324 633,116 Services and plans 336,321 289,263 271,663 Total costs applicable to revenue 1,000,910 925,587 904,779 Operating expenses: Selling, general and administrative expenses 991,883 915,355 900,798 Depreciation and amortization 98,252 99,956 97,089 Asset impairment 82,413 5,783 4,427 Other expense (income), net (164) (2,552) (2,505) Total operating expenses 1,172,384 1,018,542 999,809 Income (loss) from operations (46,826) 61,275 174,937 Interest expense, net 14,339 462 25,612 Loss on extinguishment of debt 599 — — Earnings (loss) before income taxes (61,764) 60,813 149,325 Income tax provision 4,137 18,691 21,081 Net income (loss) $ (65,901) $ 42,122 $ 128,244 Supplemental operating data: Number of stores open at end of period 1,413 1,354 1,278 New stores opened during the period 70 80 75 Adjusted Operating Income (1) $ 72,321 $ 87,795 $ 204,749 Diluted EPS $ (0.84) $ 0.52 $ 1.43 Adjusted Diluted EPS (1) $ 0.64 $ 0.65 $ 1.48 Adjusted EBITDA (1) $ 165,322 $ 180,263 $ 294,350 (1) Refer to Non-GAAP Financial Measures section below for our presentation of Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA.
The following table reconciles our Adjusted Operating Income, Adjusted Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin to net income; and Adjusted Diluted EPS to diluted EPS for the periods presented: In thousands Fiscal Year 2022 Fiscal Year 2021 Fiscal Year 2020 Net income $ 42,122 2.1 % $ 128,244 6.2 % $ 36,277 2.1 % Interest expense 462 0.0 % 25,612 1.2 % 48,327 2.8 % Income tax provision 18,691 0.9 % 21,081 1.0 % 2,403 0.1 % Stock based compensation expense (a) 13,512 0.7 % 14,886 0.7 % 10,740 0.6 % Asset impairment (b) 5,783 0.3 % 4,427 0.2 % 22,004 1.3 % Litigation settlement (c) — — % 1,500 0.1 % 4,395 0.3 % Amortization of acquisition intangibles (d) 7,488 0.4 % 7,488 0.4 % 7,426 0.4 % Other (g) (263) (0.0) % 1,511 0.1 % 2,576 0.2 % Adjusted Operating Income / Adjusted Operating Margin $ 87,795 4.4 % $ 204,749 9.8 % $ 134,148 7.8 % Note: Fiscal years 2022 and 2021 include 52 weeks.
The following table reconciles our Adjusted Operating Income, Adjusted Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin to net income; and Adjusted Diluted EPS to diluted EPS for the periods presented: In thousands Fiscal Year 2023 Fiscal Year 2022 Fiscal Year 2021 Net income $ (65,901) (3.1) % $ 42,122 2.1 % $ 128,244 6.2 % Interest expense, net 14,339 0.7 % 462 0.0 % 25,612 1.2 % Income tax provision 4,137 0.2 % 18,691 0.9 % 21,081 1.0 % Stock-based compensation expense (a) 20,174 0.9 % 13,512 0.7 % 14,886 0.7 % Loss on extinguishment of debt (b) 599 0.0 % — — % — — % Asset impairment (c) 82,413 3.9 % 5,783 0.3 % 4,427 0.2 % Litigation settlement (d) — — % — — % 1,500 0.1 % Amortization of acquisition intangibles (e) 5,251 0.2 % 7,488 0.4 % 7,488 0.4 % ERP implementation expenses (h) 484 0.0 % — — % — — % Other (i) 10,825 0.5 % (263) (0.0) % 1,511 0.1 % Adjusted Operating Income / Adjusted Operating Margin $ 72,321 3.4 % $ 87,795 4.4 % $ 204,749 9.8 % Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding.
Our participation in these programs represent an increasingly significant portion of our overall revenues and represented approximately one third of our 50 Table of Contents overall revenues in fiscal year 2022.
Our participation in these programs represent an increasingly significant portion of our overall revenues and represented approxima tely 35% of our overall revenues in fiscal year 2023 .
The key measures we use to determine how our consolidated business and operating segments are performing are net revenue, costs applicable to revenue, and selling, general, and administrative expenses, which are described further in Note 1. “Business and Significant Accounting Policies,” to our consolidated financial statements included in Part II. Item 8. of this Form 10-K.
How We Assess the Performance of Our Business We consider a variety of financial and operating measures in assessing the performance of our business. The key measures we use to determine how our consolidated business and operating segments are performing are net revenue, costs applicable to revenue, and selling, general, and administrative expenses, which are described further in Note 1.
In addition to lease commitments and contractual obligations, our material cash requirements also include operating expenses such as payroll, store rent, and advertising expenses, which we expect to fund primarily with existing cash balances and cash flows from operations. We follow U.S.
(g) Other commitments include minimum purchase commitments with certain trade vendors and contractual agreements to purchase goods or services in the ordinary course of business. 65 Table of Contents In addition to lease commitments and contractual obligations, our material cash requirements also include operating expenses such as payroll, store rent, and advertising expenses, which we expect to fund primarily with existing cash balances and cash flows from operations.
Costs of products as a percentage of net product sales decreased slightly from 47.8% for fiscal year 2020 to 47.7% for fiscal year 2021. The decrease was primarily driven by the effect of the temporary store closures in fiscal year 2020, which was partially offset by a lower mix of managed care customer transactions versus non-managed care customer transactions.
Costs of products as a percentage of net product sales decreased from 46.8% for fiscal year 2022 to 45.2% for fiscal year 2023. The decrease was primarily driven by a higher mix of managed care customer transactions versus non-managed care customer transactions.